New ed treatments 2017

Here are some new ED treatments that were approved or introduced in 2017:

  1. Stendra (Avanafil): In 2017, the FDA approved a new dose of Stendra (avanafil) for the treatment of ED. The new dose is 200mg, which is the highest dose available for the medication.
  2. Cialis (Tadalafil): In 2017, Eli Lilly and Company launched a new formulation of Cialis (tadalafil) called Cialis for Daily Use. This formulation allows men to take the medication once a day, rather than taking it as needed.
  3. Vitaros (Alprostadil): In 2017, the FDA approved Vitaros (alprostadil) for the treatment of ED. Vitaros is a topical cream that is applied to the penis to help increase blood flow and improve erections.
  4. MUSE (Alprostadil): In 2017, the FDA approved a new formulation of MUSE (alprostadil), a medication that is inserted into the urethra to help increase blood flow and improve erections.
  5. ExtenZe: In 2017, the FDA approved ExtenZe, a dietary supplement that is marketed as a natural treatment for ED. ExtenZe contains a blend of herbs and other ingredients that are believed to help improve blood flow and increase testosterone levels.
  6. Vedalafil: In 2017, the FDA approved Vedalafil, a new medication that is used to treat ED. Vedalafil works by increasing blood flow to the penis and helping to relax the muscles in the penis.
  7. Tadalafil (Adcirca): In 2017, the FDA approved a new indication for Tadalafil (Adcirca), a medication that is used to treat pulmonary arterial hypertension (PAH). The medication is also used to treat ED.

It's important to note that while these new treatments may offer improved efficacy or convenience, they may not be suitable for everyone. It's always important to talk to a healthcare professional before starting any new medication or treatment for ED.